UCA1 and central nervous system cancer: As expected, knockdown of UCA1 attenuated the EMT process in glioma cells characterized as an increase of the epithelial maker E‐cadherin expression, and decrease of the mesenchymal marker Slug expression (Fig. 3C–E).